Literature DB >> 18605771

Reducing the variation in performance of antibody titrations.

J P AuBuchon1, J de Wildt-Eggen, L J Dumont.   

Abstract

BACKGROUND: Antibody titration is difficult to standardize. We investigated whether a detailed, uniform procedure for antibody titration would reduce variation in both tube-based and gel card titres in an international study.
METHODS: Laboratories (n = 35) tested proficiency testing material provided by the College of American Pathologists each according to (i) their routine method; (ii) a detailed, uniform method; and (iii) the uniform method titrating the serum sample against a red cell of specified phenotype (D+ C- c+ E+ e- for anti-D; A(1) for anti-A) instead of the red cell of the same phenotype provided in the proficiency testing kit. Uniform method results were reported with 1+ and w+ end-points. Paired statistical analyses of variance were conducted using the F-test.
RESULTS: The variance between laboratories was not significantly reduced with the uniform method using a 1+ end-point. However, a statistically significant reduction in the variance of anti-D and anti-A titres by the tube-based uniform technique after 37 degrees C incubation and conversion to the antiglobulin (AHG) phase was seen when 19 laboratories reanalyzed their results using a w+ end-point. Too few laboratories reported results with a w+ end-point in gel card testing to allow analysis. Titration against red cells of the specified phenotype provided by the participating laboratory did not appear to introduce additional variance. Overall, results reported based on the gel card technique at the AHG phase (1+ end-point) showed reduced variance compared to tube-based techniques.
CONCLUSIONS: A detailed, uniform method for antibody titration at 37 degrees C and read at the AHG phase in a tube-based method with a w+ end-point reduced interlaboratory variability.

Mesh:

Substances:

Year:  2008        PMID: 18605771     DOI: 10.5858/2008-132-1194-RTVIPO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Antibodies to biotinylated red blood cells in adults and infants: improved detection, partial characterization, and dependence on red blood cell-biotin dose.

Authors:  Robert L Schmidt; Donald M Mock; Robert S Franco; Robert M Cohen; Anne K North; José A Cancelas; Christof Geisen; Ronald G Strauss; Alexander P Vlaar; Demet Nalbant; John A Widness
Journal:  Transfusion       Date:  2017-03-05       Impact factor: 3.157

2.  Major ABO incompatible BMT in children: determining what residual volume of donor red cells can safely be infused following red cell depletion.

Authors:  K Patrick; W Lau; A Gassas; E McDougall; J Doyle; M Ali; J Krueger; S Courtney; C Armstrong; R M Egeler; T Schechter
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

3.  A New Trial to Measure ABO Antibodies Using Complement-Dependent Cytotoxicity.

Authors:  Hee-Jeong Youk; Ho-Yoon Ryu; Suk Won Seo; Jin Seok Kim; Yousun Chung; Hyungsuk Kim; Sang-Hyun Hwang; Heung-Bum Oh; Won-Ki Min; Dae-Hyun Ko
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

Review 4.  Laboratory support of ABO antibody monitoring for ABO-incompatible solid organ transplantation.

Authors:  Yousun Chung; Dae-Hyun Ko
Journal:  Korean J Transplant       Date:  2022-05-24

5.  Quality improvement with platelet additive solution for safer out-of-group platelet transfusions.

Authors:  Maxim Tynuv; Willy A Flegel
Journal:  Immunohematology       Date:  2019-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.